Sage Therapeutics, Inc. Operating Lease, Payments
Sage Therapeutics, Inc. reported Operating Lease, Payments of $3.96 million for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-11.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:OperatingLeasePayments · last filed 2025-02-11
- Sage Therapeutics, Inc. operating lease, payments for the quarter ending 2019-12-31 was $2.54M.
- Sage Therapeutics, Inc. operating lease, payments for the quarter ending 2019-09-30 was $2.54M.
- Sage Therapeutics, Inc. operating lease, payments for the quarter ending 2019-06-30 was $2.51M.
- Sage Therapeutics, Inc. operating lease, payments for the quarter ending 2019-03-31 was $2.35M.
- Sage Therapeutics, Inc. operating lease, payments for fiscal 2024 was $3.96M, a 48.21% decline from fiscal 2023.
- Sage Therapeutics, Inc. operating lease, payments for fiscal 2023 was $7.64M, a 2.34% increase from fiscal 2022.
- Sage Therapeutics, Inc. operating lease, payments for fiscal 2022 was $7.47M, a 19.39% decline from fiscal 2021.
- Sage Therapeutics, Inc. operating lease, payments for fiscal 2021 was $9.26M, a 0.36% increase from fiscal 2020.
| Period end | Operating Lease, Payments 3 month | Operating Lease, Payments 6 month | Operating Lease, Payments 9 month | Operating Lease, Payments 12 month |
|---|---|---|---|---|
| 2024-12-31 | $3.96M 10-K · filed 2025-02-11 | |||
| 2023-12-31 | $7.64M 10-K · filed 2025-02-11 | |||
| 2022-12-31 | $7.47M 10-K · filed 2025-02-11 | |||
| 2021-12-31 | $9.26M 10-K · filed 2024-02-14 | |||
| 2020-12-31 | $9.23M 10-K · filed 2023-02-16 | |||
| 2019-12-31 | $2.54M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $5.08M derived: sum of 2 quarters · filed 2022-02-24 | $7.59M derived: sum of 3 quarters · filed 2022-02-24 | $9.95M 10-K · filed 2022-02-24 |
| 2019-09-30 | $2.54M 10-Q · filed 2019-11-12 | $5.05M derived: sum of 2 quarters · filed 2019-11-12 | $7.40M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $2.51M 10-Q · filed 2019-08-06 | $4.87M 10-Q · filed 2019-08-06 | ||
| 2019-03-31 | $2.35M 10-Q · filed 2019-05-02 |